EUVIMEDEUVIMED entdecken
Crossref

Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location

Renee R Hukkanen iD, Michelle Trapani, Tana Derringer, Victoria Laast, Zbigniew W Wojcinski, Rosa Anna Manno, Matthias Rinke iD, Eric van Esch, Alys E Bradley iD, Patrizia Cristofori, Roger Alison, Barb Munch iD

Toxicologic Pathology · 2023

DOI: 10.1177/01926233231168133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicologic Pathology, 2023. Verfasst von Renee R Hukkanen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Amgen Inc., Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Pathology, Peer Review. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxicologic/veterinary pathologists are working remotely from Good Laboratory Practice (GLP) test facilities (TFs) in increasing numbers, most commonly in home-office settings. A study pathologist (SP) generating data on GLP-compliant nonclinical studies must be keenly aware of applicable national GLP regulations and comply with TF and protocol requirements. This Toxicological Pathology Forum Opinion Piece will summarize primary areas of emphasis for the SP generating GLP data using glass slides. Peer review and digital review of whole slide images are out of scope for this opinion piece. Key GLP considerations for primary pathology on glass slides are discussed with respect to SP location and employment status, including pathologist qualifications, specimen management, facilities, equipment, archive, and quality assurance. Notable differences between national GLP regulations of the United States, the United Kingdom, Germany, the Netherlands, France, Ireland, Switzerland, Italy, and Israel are presented. With the understanding that each combination of location and employment is unique, the authors provide a general overview of considerations for successful remote GLP work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PathologyPeer ReviewHumansLaboratoriesPathologistsUnited States

Stichwörter der Autor:innen

EPAFDAGLPOECDremote histopathology

Autor:innen und Institutionen

  • Amgen Inc., Cambridge, Massachusetts, USA.
  • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • LabCorp Early Development Laboratories Inc., Madison, Wisconsin, USA.
  • Toxicology & Pathology Consulting, LLC, Hillsborough, North Carolina, USA.
  • European Research Biology Center, Rome, Italy.
  • Consultant, Wuelfrath, Germany.

ORCID-Profile: Renee R Hukkanen, Matthias Rinke, Alys E Bradley, Barb Munch

Zitieren

APA

Hukkanen, R. R., Trapani, M., Derringer, T., Laast, V., Wojcinski, Z. W., Manno, R. A., Rinke, M., van Esch, E., Bradley, A. E., Cristofori, P., Alison, R., & Munch, B. (2023). Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location. Toxicologic Pathology. https://doi.org/10.1177/01926233231168133

Vancouver

Hukkanen RR, Trapani M, Derringer T, Laast V, Wojcinski ZW, Manno RA, et al. Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location. Toxicologic Pathology. 2023. doi:10.1177/01926233231168133

BibTeX
@article{Hukkanen2023,
  author = {Hukkanen, Renee R and Trapani, Michelle and Derringer, Tana and Laast, Victoria and Wojcinski, Zbigniew W and Manno, Rosa Anna and Rinke, Matthias and van Esch, Eric and Bradley, Alys E and Cristofori, Patrizia and Alison, Roger and Munch, Barb},
  title = {Toxicologic Pathology Forum: Opinion on Performing Good Laboratory Practice Histopathology Evaluation for Nonclinical Toxicity Studies in a Remote Location},
  journal = {Toxicologic Pathology},
  year = {2023},
  doi = {10.1177/01926233231168133}
}
Kostenlos starten →